
Chatswood serves the life and health insurance sector in New Zealand with market intelligence, data, and bespoke consulting services. Some of these are provided in conjunction with Quality Product Research Limited - a subsidiary that brings you Quotemonster.
We believe that good decisions are more likely to occur when we have good information about the market environment in which we operate. Intuitive leaps and creative decisions are always required, of course, but the more they are based on a firm foundation of observation, the better they tend to be.
Munich Re look at how insurers can develop prevention strategies
Prevention is all about intervening before a disease or condition occurs – trying to extend the health span of peoples’ lives and prevent claims from arising in the first place. Munich Re’s Life Science Report looks at prevention strategies insurers can implement.
Munich Re’s Life Science Report 2025 has insights on global trends and risks that will shape the insurance industry over the next decade. We’ve written about their in-depth looks at AI in Healthcare and Improving Cancer Outcomes sections, and now we’re looking at their Prevention chapter.
Prevention is all about intervening before a disease or condition occurs – trying to extend the health span of peoples’ lives and prevent claims from arising in the first place.
In order to develop effective preventative strategies, insurers need a deep understanding of each of their clients’ unique characteristics, risk factors and health trends. Insurers should focus on areas where they’ll get the most bang for their buck, addressing lifestyle factors that contribute to the most significant preventable health risks and claims drivers – namely cardiovascular disease, cancer and mental health conditions. The key preventable causes for these are obesity, unhealthy diet, physical inactivity, smoking, excessive drinking and poor sleep patterns. Munich Re have a range of tables showing the impact of preventive measures on mortality, disability, critical illness and health care costs.
Munich Re categorise preventative health measures based on the stages of disease they are intended to prevent:
Primordial prevention - preventing development of risk factors for the entire population
Primary prevention - prevent onset of disease e.g. through lifestyle adjustments and medications
Secondary prevention - early diagnosis (e.g. through screening programmes) and prompt treatment
Tertiary prevention - manage existing disease to minimise complications and improve outcomes to prevent further morbidity and mortality
Quaternary prevention - protect from medical interventions that are likely to cause more harm than good.
To be effective, targeted interventions need to address an individual’s unique needs. By using personalised risk profiling, digital risk scores and advanced analytics, insurers can tailor interventions to maximise impact. To be efficient, insurers need to be able to amplify their prevention efforts to reach a wide audience and use digital systems to automate processes and incorporate real-time feedback. One of the most effective means of prevention is improving health literacy, the ability to navigate health information and make informed decisions. Munich Re suggest that informing policyholders about prevention benefits, enhancing health literacy, making things easy and incentivising members will all help drive positive health outcomes.
As we’ve already seen starting to occur here in NZ, insurers are positioning themselves as active participants in the well-being of their policyholders (with AIA’s Vitality programme perhaps the most notable example of this). We’d love to hear from you instances where your clients health insurance has led to them taking proactive steps to improve their health.
More news:
AIA employees return to newly renovated office space at AIA House in Smales Farm
AIA launch the third edition of Hikitia Mai, their Women in Leadership programme
Fidelity Life welcomes record number of advisers to Career Connect programme
Fidelity Life has announced the fourth intake of its adviser programme, Career connect, for new advisers and the recipients of their eight scholarships.
Fidelity Life has announced the fourth intake of its adviser programme, Career connect, for new advisers. This year sees the programme expand to welcome its largest cohort to date - 30 emerging advisers. The company will also soon invite adviser businesses to join the Career connect registry; to signal their interest in offering work experience opportunities to newly qualified financial advisers.
Submissions this year attracted greater diversity, , with 56% of applicants under the age of 35, 62% coming from female applicants and just under 30 ethnicities represented across the more than 70 applicants.
The Career connect programme awarded eight scholarships this year, up from seven last year, with each valued at up to $5,000. The recipients of the 2025 Career connect scholarships are:
Grace Leaso, Auckland - Kōwhai scholarship (for an outstanding Pasifika applicant)
Grace Shearer, Hastings - Toe Toe scholarship (for an outstanding young applicant aged 21-25)
Jada Mandery, Auckland - Women in Finance scholarship (supported by Kaplan Professional)
Marcel Stenning, Auckland - Pāua scholarship (for outstanding applicant demonstrating excellence)
Michelle Andrews, Auckland - Women in Finance scholarship (supported by Kaplan Professional)
Milly Elworthy, Mosgiel – Rural scholarship (supported by FMG)
Olivera Vasic-Wooller, Auckland - Rāngi Po scholarship (for an underrepresented community in financial services)
TK Buchanan, Christchurch - Pounamu scholarship (for an outstanding Māori applicant)
Fidelity Life Head of Solutions Michelle Doyle said
“By taking part, advice businesses play a vital role in mentoring fresh talent… It helps new advisers gain industry experience and build confidence as they transition into the profession.”
The 2025 cohort of 30 will start their journey this week. Over the next six months, they’ll take on part-time study to earn their Level 5 qualification through Kaplan Professional. Fidelity Life will host a graduation ceremony early next year to celebrate their accomplishments.
More news:
Financial Advice NZ Community of Practice: Christchurch 12 June
Introduction to Quotemonster webinar 9am, 27 May
Demystifying Advicemonster webinar 11am, 27 May
Business Risk Research and SOAs with Quotemonster webinar 12pm 29 May
Introduction to Kiwimonster webinar 12pm 26 May
Katrina Shanks and Kris Faafoi recognised on the Hot List 2025
Link Financial Group NZ appoints Anton Wicken new compliance manager
The banking industry welcomes the first reading of CCCFA amendment bill
New Zealanders will soon be able to receive 12-month prescriptions for their medicines
Munich Re look at improving Cancer outcomes
As part of Munich Re’s Life Science Report 2025, they have investigated the projected impact of advances in cancer treatment and research. These advances will change how cancers are defined, prevented, diagnosed and treated and are expected to significantly improve cancer mortality.
As part of Munich Re’s Life Science Report 2025, they have investigated the projected impact of advances in cancer treatment and research. These advances will change how cancers are defined, prevented, diagnosed and treated and are expected to significantly improve cancer mortality.
Cancer is the leading cause of death among policyholders for most insurers worldwide, as such it demands investigation. Much progress has been made in the past couple of decades to improve cancer mortality, through both reducing cancer risk factors (such as the dramatic downturn in tobacco use) and better diagnosis and treatment. Mortality improvement trends are expected to accelerate as our understanding of cancer genetics are combined with artificial intelligence (AI).
AI will be used to both improve cancer risk prevention and diagnostics. AI analysis of an individual’s personal information such as health data, family history, genetic and epigenetic profiles, microbiome, living environment and exposure history, sometimes called a statistical biopsy, will give a better understanding of risk for a wide range of cancers. This could potentially allow for a personalised approach to risks, behaviours, and identification of which strategies may be most effective in addressing these factors.
Being able to diagnose cancer more accurately, and at earlier stages, should improve cancer mortality. AI has already led to refinements in imaging studies, and in blood, urine and tissue samples. AI can also be used to analyse the tumour’s genetic pattern, other associated biomarkers and an individual’s risk profile to allow for better prognosis and management approach. AI’s ability to recognise patters not apparent to humans will help with diagnostic tools such as imaging studies, pathologic specimen interpretation and photograph analysis.
More effective screening approaches will lead to earlier cancer diagnosis and improved cancer mortality. An important technology, ‘liquid biopsy’, is currently used to analyse fluids to look for markers indicating the presence of a cancer, typically used to detect residual cancer after treatment or recurrence. If a liquid biopsy test that can screen for multiple cancers in asymptomatic individuals could be brought to market at a price point where it is accessible to the masses, it would be a game changer. Though it would also raise concerns about over-diagnosis and surveillance bias, as some identified cancers may never post a significant mortality risk.
The combination of AI and genomic analysis of tumour cells and immune cells has led to the development of targeted treatments that exploit specific genetic patterns. These treatments are more precise and safer than chemotherapy, with the four key categories of therapies emerging being targeted monoclonal antibodies, immune checkpoint inhibitors, cancer vaccines and adoptive cell immunotherapy.
With potential changes in how cancers are classified, product definitions will need to be modified. Instead of being classified based on their tissue of origin, it’s expected new cancer tests will be able to categorise cancers based on their underlying genetic causes – potentially leading to thousands of cancer subtypes.
Where previously terminal cancers become able to be managed and instead turn into chronic disease, there may be implications for living benefits products. Reduced mortality should be favourable for life insurances businesses, though the costs of more sophisticated, individualised cancer treatments may have a negative cost impact on health insurance businesses. Munich Re predict that advances in diagnosis and changes in diagnostic criteria are going to increase cancer incidence rates in the short term, but may decrease critical illness rates if major advances in cancer prevention are realised.
AI will also have implications for underwriting. AI-based diagnosis is likely to be more accurate and predictive than current methods, with fewer false positive and false negative results, enabling risk to be better assessed. Better monitoring post-cancer treatment will mean recurrence risk can be more accurately assessed too.
More news:
Southern Cross Health Trust to fund salaries of nursing positions at City Missions
Kiwi advisers believe AI could help improve advice delivery
Pharmac to fund or widen access to three treatments, including for skin cancer, from 1 June 2025
MAS announce appointment of new CEO
Jo McCauley has been appointed new Chief Executive Officer of MAS, starting 4 August 2025.
Jo McCauley has been appointed new Chief Executive Officer of MAS, starting 4 August 2025. McCauley is currently CEO of Southern Cross Travel Insurance, and she has a general insurance and consumer finance background, having led marketing, sales and product teams.
MAS Chair Brett Sutton said
“Jo brings a rare combination of leadership experience, commercial insight and strong people skills. We are excited to work with Jo as we build on a strong FY25 result and invest further in technology and service enhancements for our Members”.
More news:
AIA Group’s operating profit after tax reached $6.61 billion for 2024
Arthur J. Gallagher acquires First Capital Financial Services and First Capital Wealth Management
Gail Costa thanks advisers in her farewell message
Financial Advice NZ Special General Meeting 2025 is on 19 May in Auckland
Banking Reform Coalition wants ComCom to prosecute big four banks
AMP are looking for a Senior Application Analyst
IBANZ chief executive Mel Gorham will step down on June 26
BNZ offer relief for customers affected by recent severe weather events
ASB offer tailored emergency relief to customers affected by severe weather
Westpac's net profit after tax for the six months to March 31 was $565 million
Paddy Gower calls for Health Minister to better fund paediatric palliative care
Bigger not necessarily best when it comes to KiwiSaver
Big banks, with their brand recognition and big budgets, have long been an almost default choice for people deciding who to invest their KiwiSaver funds with. That looks like it’s starting to change.
Consumer NZ has taken a look at how KiwiSaver is going. Big banks, with their brand recognition and big budgets, have long been an almost default choice for people deciding who to invest their KiwiSaver funds with. That looks like it’s starting to change. Encouragingly, 29% of new members chose their KiwiSaver scheme independently, and 8% consulted a financial adviser about what their best option would be, though 14% were automatically allocated a default scheme. There is still some reluctance to change providers, with 12% of people feeling it’s too much hassle to change provider, 8% having thought about switching but haven’t gotten around to it and 5% not knowing where to start.
With more than 3.3 million members and more than $111 billion of total funds under management, it’s worth putting in a little effort to see which fund best suits your situation.
While banks in general are big spenders on advertising, ANZ outspends them all. Yet ANZ’s KiwiSaver returns are underwhelming, coming in last (12th) for its management of conservative KiwiSaver funds, 6th (out of 12) for moderate funds, second to last (out of 15) for balanced funds and 10th (out of 12) for growth funds, according to Morningstar’s December 2024 results. Yet ANZ holds the largest share of the KiwiSaver market, with $21.9 billion funds under management.
As of 2021, ANZ and ASB are no longer default KiwiSaver providers, leaving BT Funds (Westpac) and BNZ as the only default big bank providers for new members. It will be interesting to see how this impacts the various banks’ KiwiSaver market share over the next decade or two.
In good news, Consumers NZ’s annual survey on KiwiSaver satisfaction highlights growing satisfaction, with February 2025 results showing 82% were satisfied with their provider.
And what do people most want from their KiwiSaver provider? Good returns with responsible investments came out top (42%), followed by the best returns (37%) and investing responsibly, even if it comes with slightly lower returns (14%)
More news:
Southern Cross Health Society using Patient Feedback to celebrate surgeons
Shaun Phelan is retiring from his role as National Manager of MAS Business Advisory Services
AML Summit 2025 is on 8 - 9 May in Auckland and livestreamed
Proposed changes to Health and Safety Laws
We take a look at the proposed changes to Health and Safety laws, whereby the government wants to reduce compliance costs and provide greater certainty for businesses.
You may have seen the proposed changes to Health and Safety laws, whereby the government wants to reduce compliance costs and provide greater certainty for businesses. Bell Gully have a good summation of the proposed reforms here, but basically the Government is endeavouring to reduce the compliance burden, clarify health and safety duties (including limiting obligations for small, low-risk businesses) and clarify the distinction between governance and operational health and safety responsibilities.
There are many opposing points of view on the changes. Council of Trade Unions president Richard Wagstaff has said
"It's disappointing to see the minister has ignored the widespread consensus on what New Zealand needs to do to improve its poor track record and instead has chosen to carve out small businesses from good health and safety practices.
Exempting small businesses from best practice health and safety makes no sense when we know that small business are riskier and need more support."
Institute of Directors general manager Guy Beatson said
"Clarifying that boards are accountable for risk management and safety culture - not hands-on management - will mean directors can better focus on their core governance role without inadvertently overstepping."
Mike Cosman, chair of the Institute of Safety Management said
"The reforms are focused instead on costs to businesses of prevention and not the much greater costs of harm.
This seems to be looking through the wrong end of the telescope to us because the cost of our poor health and safety record is north of $4.9 billion per year to say nothing of the impact on workers and their families."
Russell Hutchinson has taken a look at the proposed regulations and put in his two cents.
As a country we have a not-terrible, but not-so-good track record on health and safety. One measure is fatal accidents, here I have selected countries we often use in comparisons:
Clearly, we are not as bad as, say, the United States. If we delved into that we would see significant variation on a state-by-state basis – but let’s not worry about that for now. Compared to Australia, for roughly every three people who die in a workplace accident there, four will die here. Not so good. What’s surprising is how well the UK performs – better than France and much of the EU, and better than Japan, places I normally consider to be better organised and more prescriptive in terms of employee protections. Not so! I like it when we find good data which challenges my pre-existing view. It’s a reward for paying attention to the data.
Are the proposed changes to governance liability right or wrong? One argument could be that by reducing liability on directors the workplace will become less safe. Another view is that by ensuring we place responsibility on the people who are closest to the problem we will better target the point at which better decisions can be made. Probably we will not know which until we have seen this operate for some time. Progress always seems to be so slow. Incentives also count – and the role of ACC, which has many benefits to our economy, also has some negative effects, somewhat masking the price signal in this case. I wonder if that will also get talked about.
More news:
Russell Hutchinson explains Non-Pharmac medicines coverage
AIA introducing a new excess option to AIA Private Health
AIA have updated Rules to Reinstate Policies
FSC Workplace Savings Half-Yearly Function 2025 is on 21 May
Financial Advice NZ are holding a 'Community of Practice: Central District' on 29 April
How to reduce chronic inflammation in your body
Eating well and getting regular exercise are most effective longevity tactics
Report finds deposit insurance scheme could see deposit interest rates fall significantly
Commerce Commission puts banks’ clawbacks, conversions and disincentives under scrutiny
nib research finds more adults are staying on top of essential health screenings
Recent nib research has found that more adults are staying on top of essential health screenings, but costs remain a barrier.
Recent nib research has found that more adults are staying on top of essential health screenings, but costs remain a barrier. The research was carried out in February 2025 and surveyed 1,010 Kiwi, building on the last survey conducted in December 2023. Some of the key findings include:
An increasing number of adults are keeping up with necessary health screenings - up to date with eye checks (45% up from 43%), dental check-ups (36% up from 35%), and heart health screenings (31% up from 28%).
30% believe their health is better than their peers, up from 25% in 2023.
Financial concerns are increasingly preventing Kiwi adults from accessing health checks, with 36% citing cost as a barrier (up from 29%).
80% of those with health insurance are committed to health screening checks (vs 72% overall).
More parents feel clear about which screening checks their children need (72% up from 58% in 2023).
More parents believe an annual health check is essential for their children (84% up from 75% in 2023).
More children are staying up to date with common screening tests - hearing checks (54% up from 48%), dental check-ups (66% up from 55%), eye checks (57% up from 50%) and general health exams (59% up from 57%).
Rob Hennin, Chief Executive Officer at nib New Zealand, said
“Proactive health screenings can be lifesaving and it’s really encouraging to see that Kiwi are taking the reins when it comes to their wellbeing. It’s clear to see that accessibility and cost issues continue to be barriers.”
More news:
Jason Gunn announced as new AIA Vitality Ambassador
Gallagher introduce new fundraising initiative, Gallagher Club Kickback
Partners Life go live with “no signature required” for majority of policy administration processes
mySolutions roadshows run across May in Hamilton, Wellington, Christchurch and Auckland
mySolutions webinar 'Exclusive Small Business Group Health' is on 23 April
Financial Advice NZ are holding an Ethics Workshop on 8 May
TAP webinar 'Ready to see TAP in action?' 8 May
Westpac launches a pilot for a basic transactional bank account
AI becoming more trusted by executives
SAP investigated how US executives were using AI in their organisations and their trust in the technology.
SAP investigated how US executives were using AI in their organisations and their trust in the technology. They found that AI has become embedded in work practices (with 63% of executives using generative AI daily) and is changing how people do business.
Decisions are being made based on AI insights, with 44% of C-suite executives saying they would override a decision they had already planned to make based on AI insights and another 38% trusting AI to make business decisions on their behalf. 74% of executives had more confidence in AI advice over advice from family and friends. And a massive 55% of executives say in their company AI-driven insights have replaced or bypassed traditional decision-making.
Some common tasks carried out by generative AI tools include:
Analysing data and making recommendations for decision-making (52%)
Spotting risk or issues they hadn't previously considered (48%)
Offering alternate plans (47%)
Enhancing product development (40%)
Supporting budget planning (40%)
Performing market research (40%)
SAP found that there were positive implications on employee wellbeing, with 39% of executives reporting better work-life balance, 38% reporting improved wellbeing and 31% reporting reduced stress.
More news:
SortMe Advisor Portal, a tool designed to enhance financial advisory services, launches
AIA launch new Guide to Medical Underwriting
28% of large organisations rank AI-generated cyber threats as a major risk
Steve Wright on potential implications of government’s plan to use private health care facilities for public health treatments
Good Returns has an interesting article by Steve Wright considering some of the implications of what may happen if the government goes ahead with their reported plan to consider using private health care facilities to reduce elective surgery waiting lists.
Good Returns has an interesting article by Steve Wright considering some of the implications of what may happen if the government goes ahead with their reported plan to consider using private health care facilities to reduce elective surgery waiting lists. Aside from the obvious benefits of kiwis on public health waiting lists potentially getting treated quicker, Wright considers some potential downsides, from reduced pressure to improve public sector capacity, to the private sector becoming overwhelmed or people ditching their health insurance and the private sectors viability coming into question.
We think these risks are low, given the scale of the intervention proposed by Minister Brown – just $50m to be spent between March and the end of June. For context, ACC will purchase around $500m in surgery in the 2023/24 year, and the total New Zealand Health budget is circa $16.6 billion. For an individual who gets a needed surgery a little faster, we are delighted, but this intervention is unlikely to make a big impact.
More news:
Partners Life new training module ‘Fair Treatment of Customers’
Fidelity Life offers drought-affected Taranaki customers premium relief
The FMA is on track to approve 77 licence applications under CoFI regime
Finance Minister Nicola Willis is reassessing the capital held by banks
Nominations for the Financial Advice New Zealand Awards open
The Financial Advice New Zealand Awards 2025 will be held at the National Adviser conference on Thursday 3 April, at the Te Pae Christchurch Convention Centre.
The Financial Advice New Zealand Awards 2025 will be held at the National Adviser conference on Thursday 3 April, at the Te Pae Christchurch Convention Centre. Nominations are open now, with submissions closing at 5pm on Friday 21 March.
The Financial Capability Advocate Award: presented to an individual or organisation that has made a significant effort to promote financial capability and education. The recipient of this award has played a crucial role in providing financial education to help others understand financial concepts and make informed decisions about their finances.
The Community Impact Award: recognition of an individual or organisation that has achieved excellent results in improving social and financial outcomes within a community.
The Lifetime Achievement Award: a prestigious honour given to an individual who has made a significant contribution throughout their career or lifetime to the financial services sector. It recognises their outstanding achievements, leadership, and selfless dedication to creating a positive impact on the financial advice profession.
More news:
Financial services institutions ranked among the worst for customer wait times
Health Minister outlines 5 key priorities for Health NZ
Deloitte release independent report ‘Financial Review of Health New Zealand’
Kym Maynard & Lindsey Reagan named as Insurance Business’ Elite Women 2025
ANZ customers make more than one million open banking payments